论文部分内容阅读
来自于国立卫生研究院(NIH)妇女健康促进会(WHI)的主要国际专家的初步研究结果显示,妇女接受为期7年的单一雌激素替代疗法(ERT)并不增加乳腺癌或心脏病风险。该结果与最初的妇女联合应用雌孕激素的研究结果有所差异。多伦多西奈山医院更年期科主任、妇产科医师
A preliminary study by leading international experts from the National Institutes of Health Institute for Women’s Health (WHI) showed that women receiving single-period estrogen replacement therapy (ERT) for seven years did not increase the risk of breast cancer or heart disease. The results of the initial application of estrogen and progesterone women’s research results vary. Director of Menopause Section at Mount Sinai Hospital in Toronto, obstetrics and gynecology physician